Lymphoproliferative disorders Flashcards

1
Q

How can lymphoma present?

A

lymphadenopathy or
extranodal disease or
bone marrow involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Systemic B symptoms

A
weight loss >10% in 6 months 
fever 
drenching night sweats 
pruritis 
fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How to tell what type of lymphoma it is

A

biopsy - LN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How to tell where the lymphoma is

A

CT and clinical exam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classification of “lymphoma”

A

Hodgkin

non Hodgkin - high grade and low grade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lymphoproliferative disorders

A

ALL
CLL
Hodgkin lymphoma
non Hodgkin lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

high grade NHL common type

A

diffuse large B cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

low grade NHL common type

A

follicular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ALL - blood signs

A

high WCC, low Hb and low platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

diagnosing ALL

A

> 20% lymphoblasts in the bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ALL - age

A

75% under 6 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Are most ALL B or T cell lineages?

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ALL - history of symptoms

A

bone marrow failure

bone/joint pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Standard treatment for ALL

A

induction chemo
consolidation therapy
CNS directed treatment - intrathecal
maintenance treatment for 18 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Who would receive a stem cell transplant for ALL?

A

high risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

newer therapies for ALL

A

bispecific T cell engagers - BiTe

CAR

17
Q

problems with newer therapies for ALL

A

cytokine release syndrome

neurotoxicity

18
Q

ALL poor risk factors

A
increasing age 
increasing WCC
immunophenotyped
cytogenetics - Philadelphia gene
slow/poor response to treatment
19
Q

CLL diagnosis

A

blood >5x10 9 lymphocytes, bone marrow >30% lymphocytes

20
Q

Presentation of CLL

A

often asymptomatic
frequent findings = splenomegaly, bone marrow failure, lymphadenopathy, fever, sweats
less common = hepatomegaly, infections, weight loss

21
Q

Associated findings with CLL

A

immunoparesis

haemolytic anaemia

22
Q

Staging for CLL

23
Q

Indication for treatment - CLL

A

massive lymphadenopathy
progressive splenomegaly
progressive bone marrow failure
systemic symptoms

24
Q

CLL treatment

A

often nothing
cytotoxic chemo
monoclonal ab
novel agent eg tyrosine kinase inhibitor

25
CLL poor prognostic factors
advanced disease - Binet's atypical lymphocyte morphology loss/mutation p53 rapid lymphocyte doubling time
26
Staging lymphoma
LN biopsy CT bone marrow aspirate and trephine
27
High grade NHL
aggressive and fast growing combo chemo required can be cured
28
low grade NHL
indolent, often asymptomatic responds to chemo incurable
29
combo chemo for NHL
Anti CD20 mab and chemo
30
Epidemiology of HL
30% of all lymphomas bimodal age curve EBV males
31
HL treatment
combo chemo (ABVD) +/- radiotherapy monoclonal ab (anti-CD30) immunotherapy PET scan to monitor response